Media Library

Exterior view of our large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

Highly trained specialists on the production line of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

Examining materials inside the refrigeration room of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

Using specialized equipment on the production line at our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

Conducting quality control at our state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards. View the online summary

B-roll footage of our large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.

This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also contains our operating and financial results, accompanied by audited annual financial statements.

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards. View the online summary

President, International, since December 1, 2023

President, International, since December 1, 2023

President, International, since December 1, 2023